Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
June 4, 2023

Poster HER2-low presented at ASCO2023

Poster HER2-low presented at ASCO2023

Our #ASCO2023 poster on HER2-low was selected for oral presentation by session chair Prof. David Rimm (Yale University School of Medicine). In his discussion he highlighted AI as an essential means to score HER2 in the future. The paper “AI-based HER2-low IHC scoring in breast cancer across multiple sites, clones and scanners” was written together with PD Dr. med. habil. Ramona Erber, Arndt Hartmann, Evgeny / Евгений Dr. Minin / Минин, Hanna Hübner, Carolin Schmidt, Ralf Banisch, Stefan Gunther, Patrick Frey, Tobias Lang, Matthias Ruebner, Peter Andreas Fasching, Niklas Abele, Andreas Mamilos. Thank you to all contributors!

You may also be interested in

October 4, 2024
Mindpeak secures $15.3M in series A funding to accelerate growth in AI-based digital pathology

Mindpeak secures $15.3M in series A funding to accelerate growth in AI-based digital pathology Funding strengthens the product development roadmap for AI-powered histopathological assessments, supporting clinical labs and biopharma companies worldwide.

Read more ⟶
June 9, 2024
Mindpeak expands portfolio, releases Artificial Intelligence for Prostate Cancer

Mindpeak unveiled a new product to empower pathologists in detecting and grading prostate cancer.

Read more ⟶
August 28, 2024
ECP 2024 in Florence: Come visit us!

Unlocking the Future of Pathology with AI: Meet our Team at ECP 2024

Read more ⟶

Find out more about our AI-based diagnostics

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mindpeak Breast IHC being displayed on a monitor

About Mindpeak

We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in providing reliable and reproducible diagnoses.
‍
This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable. Explainable AI (xAI) results provide the required trust of pathologists into our tools.

Company information

Local court Hamburg HRB 151143
‍
Managing director:
Felix Faber
‍
V.A.T. identification number:
DE318495606

Founded in 2018

Contact us

Mindpeak GmbH
Zirkusweg 2
20359 Hamburg
Germany
Email: info@mindpeak.ai
Telephone: +49 40 35 67 67 97

Regulatory Note:
Unless otherwise stated all products are intended for Research Use Only, not for use in diagnostic procedures.

© 2024 Mindpeak GmbH

Supported by:

Horizon 2020 (European Commission)

Privacy policy

Contact